Lipoprotein (a) Levels in Childhood Arterial Ischemic Stroke

Abstract

Lipoprotein (a) is a cholesterol-rich plasma lipoprotein with a lipid composition similar to that of low-density lipoproteins (LDL). Many prospective and case-control studies identified elevated levels of lipoprotein (a) as a risk factor for premature myocardial infarction and stroke. Elevated lipoprotein (a) has been identified as a genetically determined risk factor for stroke in young adults, but only preliminary data are available on its role as a risk factor for ischemic stroke in infants and children.

Fifty two children with arterial ischemic stroke and 78 age- and sex-matched healthy children were studied. Data of this study indicate that 26.9% of children with arterial ischemic stroke had high lipoprotein (a) levels in comparison with the age matched healthy control group.

Measurement of lipoprotein (a) should be included in screening programs performed in young patients suffering not only from venous thromboembolism but also arterial ischemic stroke, in addition to other thrombophilic factors.

Keywords

childhood ischemic stroke lipoprotein (a)

References

Schoenberg BS , Mellinger JF , Schoenberg DG Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology . 1978; 28(8):763-768.

Riela AR , Roach ES Etiology of stroke in children. J Child Neurol. 1993;8(3):201-220.

Lynch JK , Hirtz DG , deVeber G. , Nelson KB Report of the national institute of neurological disorders and stroke workshop on perinatal and childhood stroke. Pediatrics. 2002;109(1):116-123.

Giroud M. , Lemesle M. , Gouyon JB , Nivelon JL , Milan C. , Dumas R. Cerebrovascular disease in children under 16 years of age in Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol. 1995;48(11):1343-1348.

Jordan LC Stroke in childhood. Neurologist. 2006; 12(2):94-102.

Akar N. Molecular approach to Turkish pediatric stroke patients. Turk J Hematol. 2002;19(2):245-253.

Armstrong VW , Walli AK , Seidel D. Isolation, characterization and uptake in human fibroblasts of an apo (a)-free lipoprotein obtained on reduction of lipoprotein (a). J Lipid Res. 1985;26(11):1314-1323.

Seman LJ , Breckenridge WC Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a). Biochem Cell Biol. 1986;64(10):999-1009.

Caplice NM , Panetta C. , Peterson TE , et al. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood. 2001;98(10):2980-2987.

10.

Rader DJ , Hoeg JM , Brewer HB Jr. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med. 1994;120(12):1012-1015.

11.

Maher VM , Brown BG Lipoprotein(a) and coronary heart disease. Curr Opin Lipidol . 1995;6(4):229-235.

12.

Rosengren A. , Wilhelmsen L. , Eriksson E. , Risberg B. , Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case control study in a general population of middle-aged men . BMJ. 1990;301(6763):1248-1251.

13.

Nowak-Gottl U. , Debus O. , Findeisen M. , et al. Lipoprotein (a): its role in childhood thromboembolism. Pediatrics. 1997;99(6):E11.

14.

Jurgens G. , Koltringer P. Lipoprotein (a) in ischemic cerebrovascular disease: a new approach to the assessment of risk of stroke. Neurology. 1987 ;37(3):513-515.

15.

Sträter R. , Becker S. , von Eckardstein A. , et al. Prospective assessment of risk factors for recurrent stroke during childhood a 5-year follow-up study . Lancet. 2002;16; 360(9345):1540-1545.

16.

Akar N. Site specific mutagenesis: usage for the mutation detection in thrombosis . Turk J Haematol. 1998; 15(3):123-124.

17.

Nowak-Gottl U. , Strater R. , Heinecke A. , et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999;94(11):3678-3682.

18.

Nowak-Gottl U. , Junker R. , Hartmeier M. , et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation . 1999; 100(7):743-748.

19.

Gözdaşoğlu S. , Uysal Z. , Ertem M. , Akar N. Three risk factors-high lipoprotein (a), elevated FVIII, and FV Leiden-in a pediatric Behçet’s disease patient with deep vein thrombosis. Thromb Res. 2002 ;106(4-5):263.

20.

Gürbüz O. , Ozdemir Y. , Coşar CB , Kural G. Lipoprotein (a) in Behçet’s disease as an indicator of disease activity and in thrombotic complications. Eur J Ophthalmol. 2001;11(1):62-65.